For example, CD126 blocking antibody enhanced chemotherapy on chemoresistant chronic lymphocytic leukemia cells, which display active signaling through the IL6/CD126/STAT3 axis (Liu et al., 2015). This evidence concerns the gene IL6R and B-cell chronic lymphocytic leukemia.